X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 63 filers reported holding X4 PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,578 | +12.4% | 4,200 | +100.0% | 0.00% | – |
| Q2 2023 | $4,074 | +123.0% | 2,100 | 0.0% | 0.00% | – |
| Q1 2023 | $1,827 | -12.4% | 2,100 | 0.0% | 0.00% | – |
| Q4 2022 | $2,085 | -47.9% | 2,100 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | +100.0% | 2,100 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 2,100 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -20.0% | 2,100 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | +400.0% | 2,100 | +2000.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |